These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 2989331)

  • 1. Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications.
    Schulte HM; Chrousos GP; Gold PW; Booth JD; Oldfield EH; Cutler GB; Loriaux DL
    J Clin Invest; 1985 Jun; 75(6):1781-5. PubMed ID: 2989331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses of plasma adrenocorticotropin and cortisol to intravenous injection of synthetic ovine corticotropin releasing factor in the morning and early evening in normal human subjects.
    Watabe T; Tanaka K; Hasegawa M; Miyabe S; Shimizu N
    Endocrinol Jpn; 1985 Oct; 32(5):771-9. PubMed ID: 3004929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol.
    Orth DN; Jackson RV; DeCherney GS; DeBold CR; Alexander AN; Island DP; Rivier J; Rivier C; Spiess J; Vale W
    J Clin Invest; 1983 Mar; 71(3):587-95. PubMed ID: 6298280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies for clinical application of ovine corticotropin-releasing factor].
    Kubo M
    Hokkaido Igaku Zasshi; 1985 Mar; 60(2):282-98. PubMed ID: 2987091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing factor (CRF): stimulation in normal controls and in patients with Cushing's syndrome.
    Müller OA; Hartwimmer J; Hauer A; Kaliebe T; Schopohl J; Stalla GK; von Werder K
    Psychoneuroendocrinology; 1986; 11(1):49-60. PubMed ID: 3010360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diurnal variation in the response of plasma adrenocorticotropin and cortisol to intravenous ovine corticotropin-releasing hormone.
    DeCherney GS; DeBold CR; Jackson RV; Sheldon WR; Island DP; Orth DN
    J Clin Endocrinol Metab; 1985 Aug; 61(2):273-9. PubMed ID: 2989316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
    Nakahara M; Shibasaki T; Shizume K; Kiyosawa Y; Odagiri E; Suda T; Yamaguchi H; Tsushima T; Demura H; Maeda T
    J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
    Lamberts SW; Verleun T; Oosterom R; de Jong F; Hackeng WH
    J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man.
    Debold CR; Jackson RV; Kamilaris TC; Sheldon WR; Decherney GS; Island DP; Orth DN
    J Clin Endocrinol Metab; 1989 Feb; 68(2):431-7. PubMed ID: 2537333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cortisol infusion on basal and corticotropin-releasing factor (CRF)-stimulated plasma ACTH concentrations in the sheep fetus after surgical isolation of the pituitary.
    Ozolins IZ; Young IR; McMillen IC
    Endocrinology; 1990 Oct; 127(4):1833-40. PubMed ID: 2169403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovine corticotropin-releasing factor administration in normal men. Pituitary and adrenal responses in the morning and evening.
    Schulte HM; Chrousos GP; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
    Horm Res; 1985; 21(2):69-74. PubMed ID: 2984099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACTH and cortisol responses to ovine corticotrophin-releasing factor in patients with primary and secondary adrenal failure.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    Clin Endocrinol (Oxf); 1985 Jun; 22(6):761-9. PubMed ID: 2990763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin releasing factor (CRF): diagnostic implications.
    Müller OA; Stalla GK; Hartwimmer J; Schopohl J; von Werder K
    Acta Neurochir (Wien); 1985; 75(1-4):49-59. PubMed ID: 2986422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma adrenocorticotropin and cortisol responses to ovine corticotropin-releasing factor in patients with adrenocortical insufficiency due to hypothalamic and pituitary disorders.
    Tsukada T; Nakai Y; Koh T; Tsujii S; Inada M; Nishikawa M; Shinoda H; Kawai I; Takezawa N; Imura H
    J Clin Endocrinol Metab; 1984 Apr; 58(4):758-60. PubMed ID: 6321536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of synthetic ovine corticotropin-releasing factor: prolonged duration of action and biphasic response of plasma adrenocorticotropin and cortisol.
    DeBold CR; DeCherney GS; Jackson RV; Sheldon WR; Alexander AN; Island DP; Rivier J; Vale W; Orth DN
    J Clin Endocrinol Metab; 1983 Aug; 57(2):294-8. PubMed ID: 6306038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin releasing factor: basic studies and clinical applications.
    Chrousos GP; Calabrese JR; Avgerinos P; Kling MA; Rubinow D; Oldfield EH; Schuermeyer T; Kellner CH; Cutler GB; Loriaux DL
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):349-59. PubMed ID: 2999871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of subcutaneous and intranasal administration of ovine corticotropin-releasing hormone in man: comparison with intravenous administration.
    DeBold CR; Sheldon WR; DeCherney GS; Jackson RV; Nicholson WE; Island DP; Orth DN
    J Clin Endocrinol Metab; 1985 May; 60(5):836-40. PubMed ID: 2984233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ovine corticotropin-releasing hormone administered during insulin-induced hypoglycemia on plasma adrenocorticotropin and cortisol.
    DeCherney GS; DeBold CR; Jackson RV; Sheldon WR; Kamilaris TC; Island DP; Orth DN
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1211-8. PubMed ID: 3033009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.